Literature DB >> 20056953

Exploring a cancer biomarker: the example of C-reactive protein.

Paolo Boffetta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20056953     DOI： 10.1093/jnci/djp511

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study.

Authors:  Mieke Van Hemelrijck; Lars Holmberg; Hans Garmo; Niklas Hammar; Göran Walldius; Elisa Binda; Mats Lambe; Ingmar Jungner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-04       Impact factor: 4.254

2.  Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma.

Authors:  Matthias Reeh; Tarik Ghadban; Faik G Uzunoglu; Michael F Nentwich; Maximilian Bockhorn; Klaus Pantel; Jakob R Izbicki; Yogesh K Vashist
Journal:  Br J Cancer       Date:  2017-07-13       Impact factor: 7.640

3.  Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients.

Authors:  Shan-Shan Jiang; Long Jiang; De-Sheng Weng; Yuan-Fang Li; Qiu-Zhong Pan; Jing-Jing Zhao; Yan Tang; Zhi-Wei Zhou; Jian-Chuan Xia
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

4.  Platelet-to-lymphocyte ratio is correlated with a delay in feeding resumption following a transhiatal esophagectomy with cervical anastomosis.

Authors:  Antoine El Asmar; Elie Ghabi; Toufic Saber; Christina Abou-Malhab; Bernard Akl; Ziad El Rassi
Journal:  World J Surg Oncol       Date:  2020-10-14       Impact factor: 2.754

5.  Systematic review of Mendelian randomization studies on risk of cancer.

Authors:  Georgios Markozannes; Afroditi Kanellopoulou; Olympia Dimopoulou; Dimitrios Kosmidis; Xiaomeng Zhang; Lijuan Wang; Evropi Theodoratou; Dipender Gill; Stephen Burgess; Konstantinos K Tsilidis
Journal:  BMC Med       Date:  2022-02-02       Impact factor: 11.150
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.